All Episodes
#61·May 22, 2025

Sherry Rais

From Taboo to Transformative – The Psychedelic Renaissance is Here

Sherry Rais, CEO of Enthea, shares how her experience in global development led her to make psychedelic-assisted therapies—psilocybin, MDMA, and ketamine—accessible through corporate workplace benefits, with an ambition to heal one billion people.

Psychedelics

In this transformative episode of Catalyzing Radical Systemic Change, host Alistair Langer dives deep with Sherry Rais, Co-Founder and CEO of Enthea, a pioneering company making psychedelic-assisted therapies accessible through workplace benefits.     From her early work with the UN and World Bank to founding Enthea, Sherry’s journey reflects a bold vision for revolutionizing mental health care. She shares how witnessing the global mental health crisis firsthand inspired her to pursue evidence-based psychedelic therapies as a scalable, effective solution.     Highlights:   From Global Development to Psychedelic Innovation – How Sherry’s work in poverty reduction led her to discover the healing potential of psychedelics.   The Psychedelic Renaissance – Why MDMA, psilocybin, and ketamine are poised to disrupt traditional mental health treatments.   Scaling Impact with Enthea – The path to treating millions through corporate benefits and the long-term vision of healing one billion people.   Cultural Shift – How public figures and mainstream media are driving a new conversation around mental health.     About Sherry Rais:   Sherry Rais is the Co-Founder and CEO of Enthea, a company dedicated to making psychedelic-assisted therapies a standard workplace benefit. With a background in global health and policy, Sherry’s mission is to provide safe, affordable access to transformative mental health treatments.


Work with Alistair

If this conversation sparked something — a question, a recognition, an edge you're sitting with — that's often where the real work begins.